参考文献/References:
[1].Hurst RT, Prasad A, Rd AJ, et al. Takotsubo cardiomyopathy:a unique cardiomyopathy with variable ventricular morphology[J]. JACC Cardiovasc Imaging,2010,3(6):641-649.
[2].Lyon AR,Bossone E,Schneider B,et al. Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology[J]. Eur J Heart Fail,2016,18(1):8-27.
[3].Schneider B, Athanasiadis A, St?llberger C, et al. Gender differences in the manifestation of tako-tsubo cardiomyopathy[J]. Int J Cardiol,2013,166(3):584-588.
[4].Frangieh AH, Obeid S, Ghadri J, et al. ECG criteria to differentiate between takotsubo (stress) cardiomyopathy and myocardial infarction[J]. J Am Heart Assoc Cardiovasc Cerebrovasc Dis,2016,5(6):e003418.
[5].Tamura A,Watanabe T,Ishihara M,et al. A new electrocardiographic criterion to differentiate between Takotsubo cardiomyopathy and anterior wall ST-segment elevation acute myocardial infarction[J]. Am J Cardiol,2011,108(5):630-633.
[6].Budnik M,Kochanowski J,Piatkowski R,et al. Simple markers can distinguish Takotsubo cardiomyopathy from ST segment elevation myocardial infarction[J]. Int J Cardiol,2016,219:417-420.
[7].Pirzer R,Elmas E,Haghi D,et al. Platelet and monocyte activity markers and mediators of inflammation in Takotsubo cardiomyopathy[J]. Heart Vessels,2012,27(2):186-192.
[8].Dwivedi Y. Evidence demonstrating role of microRNAs in the etiopathology of major depression[J]. J Chem Neuroanat,2011,42(2):142-156.
[9].Nagueh SF,Smiseth OA,Appleton CP,et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J]. Eur Heart J Cardiovasc Imaging,2016,29(4):277-314.
[10].Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J]. Eur Heart J Cardiovasc Imaging,2015,16(3):233-270.
[11].Christensen TE, Ahtarovski KA, Bang LE, et al. Basal hyperaemia is the primary abnormality of perfusion in Takotsubo cardiomyopathy:a quantitative cardiac perfusion positron emission tomography study[J]. Eur Heart J Cardiovasc Imaging,2015,16(10):1162-1169.
[12].Ghadri JR,Wittstein IS,Prasad A,et al. International expert consensus document on Takotsubo syndrome (partⅡ): diagnostic workup, outcome, and management[J]. Eur Heart J,2018,39(22):2047-2062.
[13].Ghadri JR, Wittstein IS, Prasad A, et al. International expert consensus document on Takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology[J]. Eur Heart J,2018,39(22):2032-2046.
[14].St?llberger C,Wegner C,Finsterer J. Seizure-associated Takotsubo cardiomyopathy[J]. Epilepsia,2011,52(11):e160-e167.
[15].Giavarini A,Chedid A,Bobrie G,et al. Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma[J]. Heart,2013,99(19):1438-1444.
[16].Santoro F, Ieva R, Ferraretti A, et al. Safety and feasibility of levosimendan administration in Takotsubo cardiomyopathy:a case series[J]. Cardiovasc Ther,2013,31(6):e133-e137.
[17].Madias JE. If channel blocker ivabradine vs. β-blockers for sinus tachycardia in patients with takotsubo syndrome[J]. Int J Cardiol,2016,223:877-878.
[18].Stiermaier T,Rommel KP, Eitel C,et al. Management of arrhythmias in patients with Takotsubo cardiomyopathy:is the implantation of permanent devices necessary[J]. Heart Rhythm,2016,13(10):1979-1986.
[19]..Marra MP, Zorzi A, Corbetti F, et al. Apicobasal gradient of left ventricular myocardial edema underlies transient T-wave inversion and QT interval prolongation (Wellens’ ECG pattern) in Tako-Tsubo cardiomyopathy[J]. Heart Rhythm,2013,10(1):70-77.
[20].Ueyama T,Ishikura F,Matsuda A,et al. Chronic estrogen supplementation following ovariectomy improves the emotional stress-induced cardiovascular responses by indirect action on the nervous system and by direct action on the heart[J]. Circ J,2007,71(4):565.
[21].Ghadri JR,Sarcon A,Diekmann J,et al. Happy heart syndrome:role of positive emotional stress in takotsubo syndrome[J]. Eur Heart J,2016,37(37):2823-2829.
[22].Redmond M,Knapp C,Salim M,et al. Use of vasopressors in Takotsubo cardiomyopathy:a cautionary tale[J]. Br J Anaesth,2013,110(3):487-488.
相似文献/References:
[1]韩雅君,朱慧,王丽媛,等.虚拟组织学对急性冠状动脉综合征患者斑块评价研究进展[J].心血管病学进展,2015,(5):641.[doi:10.3969/j.issn.1004-3934.2015.05.031]
HAN Yajun,ZHU Hui,WANG Liyuan,et al.Evaluating Plaque in Patients with Acute Coronary Syndrome by Intravascular
Ultrasound with Virtual Histology[J].Advances in Cardiovascular Diseases,2015,(5):641.[doi:10.3969/j.issn.1004-3934.2015.05.031]
[2]郭远林.急性冠状动脉综合征风险评估方法学进展[J].心血管病学进展,2015,(6):681.[doi:10.3969/j.issn.1004-3934.2015.06.007]
GUO Yuanlin,YAN Hongbin.Progress in Tools for Risk Assessment of Acute Coronary Syndromes[J].Advances in Cardiovascular Diseases,2015,(5):681.[doi:10.3969/j.issn.1004-3934.2015.06.007]
[3]魏恒争,木胡牙提.比伐卢定在急性冠状动脉综合征患者PCI中的应用进展[J].心血管病学进展,2015,(6):725.[doi:10.3969/j.issn.1004-3934.2015.06.017]
WEI Hengzheng,MUHU Yati.Advance in Research of Bivalirudin During Percutaneous Coronary Intervention
in Patients with Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2015,(5):725.[doi:10.3969/j.issn.1004-3934.2015.06.017]
[4]王振伟 王涟 徐标.应激性心肌病患者临床特点及预后分析[J].心血管病学进展,2019,(5):831.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.041]
WANG Zhenwei,WANG Lian,XU Biao.Clinical Features and Prognosis of Patients with Takotsubo Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(5):831.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.041]
[5]白斯特 潘建华 蔡梦珊 姜馨.白介素-1家族在急性冠状动脉综合征发生和发展过程中的机制及治疗现状进展[J].心血管病学进展,2022,(1):64.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.017]
BAI Site,PAN Jianhua,CAI Mengshan,et al.Mechanism and Treatment Status of Interleukin-1 Family in Occurrence and Development of Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2022,(5):64.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.017]
[6]陈纪元 陆泓雨 贺子熠 韩江莉.冠心病合并慢性肾脏病患者P2Y12受体拮抗剂治疗进展[J].心血管病学进展,2022,(7):582.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
CHEN Jiyuan,LU Hongyu,HE Ziyi,et al.P2Y12 Antagonists for Patients with Chronic Kidney Diseases and Coronary Heart Diseases[J].Advances in Cardiovascular Diseases,2022,(5):582.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[7]唐琛 史宏志 韩红亚 刘晓丽 赵亦骢 王琛茜 张佳宜.应激性心肌病的研究进展[J].心血管病学进展,2024,(7):593.[doi:10.16806/j.cnki.issn.1004-3934.2024.07.005]
TANG Chen,SHI Hongzhi,HAN Hongya,et al.Stress-Induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2024,(5):593.[doi:10.16806/j.cnki.issn.1004-3934.2024.07.005]